Authors:
Barolet, AW
Nili, N
Cheema, A
Robinson, R
Natarajan, MK
O'Blenes, S
Li, J
Eskandarian, MR
Sparkes, J
Rabinovitch, M
Strauss, BH
Citation: Aw. Barolet et al., Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor, ART THROM V, 21(8), 2001, pp. 1269-1274
Authors:
Jong, P
Cohen, EA
Batchelor, W
Lazzam, C
Kreatsoulas, C
Natarajan, MK
Strauss, BH
Citation: P. Jong et al., Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction, AM HEART J, 141(2), 2001, pp. 218-225
Authors:
Velianou, JL
Strauss, BH
Kreatsoulas, C
Pericak, D
Natarajan, MK
Citation: Jl. Velianou et al., Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In-hospital and six-month outcomes, CATHET C IN, 51(2), 2000, pp. 138-144
Authors:
Miner, SES
Hegele, RA
Sparkes, J
Teitel, JM
Bowman, KA
Connelly, PW
Banijamali, H
Lau, HK
Chisholm, RJ
Babaei, S
Strauss, BH
Citation: Ses. Miner et al., Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: A prospective study, AM HEART J, 140(2), 2000, pp. 272-278
Authors:
Cantor, WJ
Leblanc, K
Garvey, B
Watson, KR
Rasymas, A
Strauss, BH
Citation: Wj. Cantor et al., Combined use of Orgaran and Reopro during coronary angioplasty in patientsunable to receive heparin, CATHET C IN, 46(3), 1999, pp. 352-355
Citation: Tj. Gray et al., Inhibitory mechanisms by which suramin may attenuate neointimal formation after balloon angioplasty, J CARDIO PH, 33(6), 1999, pp. 960-971